Avista Capital Partners

Avista Capital Partners Acquires GCM, A Leading Outsourced Component Manufacturer For The MedTech Industry | PR Newswire | 9/3/2019

… excellent hands going forward with Avista – a collaborative partner who recognizes and values the unique attributes and long-term sustainability of the Company.” Avista’s legal advisor is Ropes & Gray LLP. GCM’s financial advisor is William Blair & Company. GCM’s legal advisor is Paul Hastings LLP. About May River Capital May River Capital is a Chicago -based private equity firm focused on investing in lower middle market industrial growth companies. May River …

Organogenesis Announces Completion of Exchange Offer and Plan to Exchange Remaining Outstanding Public Warrants | Globe Newswire | 8/19/2019

… including the Amended and Restated Offer to Exchange Letter and Consent Solicitation, Amended and Restated Letter of Transmittal and Consent and other related documents. About Organogenesis Holdings Inc. Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair …

Follow Avista Capital Partners:    

Karo Pharma: Interim Report January - June 2019 | Markets Insider | Business Insider | 7/19/2019

… share were SEK 0.21 (5.07), of which the second quarter amounted to SEK -0.04 (3.86). For 2019, earnings per share are affected by costs affecting comparability and for 2018 by a milestone payment from Pfizer and recognition of deferred tax assets on loss carry forwards (417,7 MSEK). Cash and short-term investments at period end amounted to MSEK 561.2 (398.6 as of December 31, 2018 ). On April 3 , it was …

Avista Capital Partners To Sell Trimb To Karo Pharma | 6/25/2019

Avista Capital Partners To Sell Trimb To Karo Pharma Published: Jun 25, 2019 NEW YORK and STOCKHOLM , June 25, 2019 /PRNewswire/ – Avista Capital Partners (“Avista”), a leading private equity firm focused on growth-oriented healthcare businesses, today announced that Karo Pharma AB (publ) (the “Company” or “Karo Pharma”), a specialty pharma company, has acquired all the shares of Trimb Holding AB (“Trimb”) for approximately $366 million (USD). The transaction is …

Karo Pharma buys Swedish consumer healthcare firm Trimb | PE Hub | 6/25/2019

… company, for about $366 million. The deal is expected to close before the end of the year. Trimb was backed by Avista Capital Partners. PRESS RELEASE NEW YORK and STOCKHOLM, June 25, 2019 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused on growth-oriented healthcare businesses, today announced that Karo Pharma AB (publ) (the “Company” or “Karo Pharma”), a specialty pharma company, has acquired all the shares …

Karo Pharma To Acquire Trimb Healthcare from Avista Capital Partners | PR Newswire | 6/25/2019

NEW YORK and STOCKHOLM , June 25, Avista Capital Partners (“Avista”), a leading private equity firm focused on growth-oriented healthcare businesses, announced the signing of a definitive agreement whereby Karo Pharma AB (publ) (“Karo Pharma”), a specialty pharma company, will acquire Trimb Healthcare (“Trimb”) for approximately SEK 3.4 billion. The transaction is subject to customary competition authority review and is expected to close later this year. Founded in 2012, Trimb …

Karo Pharma acquires Trimb for MSEK 3,400 and intends to carry out a rights issue of approximately MSEK 1,500 | 6/21/2019

Karo Pharma acquires Trimb for MSEK 3,400 and intends to carry out a rights issue of approximately MSEK 1,500 Fri, Jun 21, 2019 01:30 CET Karo Pharma AB (publ) (the ” Company ” or ” Karo Pharma ”) has today acquired all the shares of Trimb Holding AB (“ Trimb ”) from Avista Capital Partners (“ Avista ”) and other shareholders for MSEK 3,400 (the ” Transaction ”). The Transaction is expected to contribute positively to Karo Pharma’s market position …

Physician practices increasingly turn to private equity for capital | Modern Healthcare | 4/26/2019

… OptumCare, for a share of ownership. “The fact is it’s becoming more complex and burdensome to manage a physician practice,” Ryan Lucero, a vice president in the Seattle office of private-equity firm Frazier Healthcare Partners, said during an event in New York on Thursday hosted by the law firm Epstein Becker & Green. “Compliance and regulation is going up and reimbursement is going down.” New York providers have captured some …

3 Reasons Bristol-Myers Could Become One Of The Best Investments Of The Next 5 Years - Bristol-Myers Squibb Company (NYSE:BMY) | Seeking Alpha | 4/9/2019

… the US but 50% of drug spending . Bristol-Myers has spent years steadily selling off non-patented drug businesses including: diabetes business to AstraZeneca ( AZN ) in a $4.1 billion deal in 2014 its medical imaging group to Avista Capital Partners for $525 million in late 2017 its wound-care division to the Nordic Capital Fund 7 for $4.1 billion in 2008 spinning off Mead-Johnson , its infant nutrition business in …

ACA

Miraca Life Sciences Announces Company Name Change to Inform Diagnostics | Business Wire | 1/9/2018

IRVING, Texas- Miraca Life Sciences announced today that it has changed its name to Inform Diagnostics effective immediately. The company was acquired in November by Avista Capital Partners from previous owner Miraca Holdings. The name Inform Diagnostics and new logo were chosen to highlight the company’s focus on providing pathology and diagnostic capabilities that together help inform clinicians and their patients about critical, health-related issues. “Although our name has …

AMA

New York’s Answer to Davos: Wall Street Pong, Louis Armstrong - Bloomberg | 1/26/2018

… Management also sent players, and WeWork hosted a pre-party. Andrew Lipman of TA McKay & Co. and Phil Seskin of Avista Capital Partners founded the event to raise money and recruit mentors. It’s played on … joined Wycliffe Gordon to perform “What a Wonderful World.” Photograhper: Amanda Gordon/Bloomberg But something new is coming: an education center will be built in the next couple of years featuring a 68-seat jazz …

Miraca Life Sciences Announces Company Name Change to Inform Diagnostics | Business Wire | 1/9/2018

… announced today that it has changed its name to Inform Diagnostics effective immediately. The company was acquired in November by Avista Capital Partners from previous owner Miraca Holdings. The name Inform Diagnostics and new logo … Additionally, a large non-laboratory office is located in Daphne, Alabama, as well as smaller offices and laboratories in other cities. Previously known as Miraca Life Sciences since 2012, Inform Diagnostics provides proven high-quality …

Formulary Management

Avista Capital Partners to Acquire Express Scripts’ Subsidiary United BioSource | PR Newswire | 11/27/2017

Avista Capital Partners to Acquire Express Scripts’ Subsidiary United BioSource News provided by 09:15 ET Share this article ST. LOUIS and NEW YORK , Nov. 27, Express Scripts (NASDAQ: ESRX ) and Avista Capital Partners, a leading … care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and

Avista Capital Partners to Acquire Express Scripts’ Subsidiary United BioSource | PR Newswire | 11/27/2017

ST. LOUIS and NEW YORK , Nov. 27, Express Scripts (NASDAQ: ESRX ) and Avista Capital Partners, a leading private equity firm, announced today that Avista has signed a definitive agreement to acquire United BioSource (UBC), a … care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and

Pharmacy Benefit Management

Avista Capital Partners to Acquire Express Scripts’ Subsidiary United BioSource | PR Newswire | 11/27/2017

Avista Capital Partners to Acquire Express Scripts’ Subsidiary United BioSource News provided by 09:15 ET Share this article ST. LOUIS and NEW YORK , Nov. 27, Express Scripts (NASDAQ: ESRX ) and Avista Capital Partners, a leading … and accessible. Headquartered in St. Louis , Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review

Avista Capital Partners to Acquire Express Scripts’ Subsidiary United BioSource | PR Newswire | 11/27/2017

ST. LOUIS and NEW YORK , Nov. 27, Express Scripts (NASDAQ: ESRX ) and Avista Capital Partners, a leading private equity firm, announced today that Avista has signed a definitive agreement to acquire United BioSource (UBC), a … and accessible. Headquartered in St. Louis , Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review

Home Delivery Pharmacy

Avista Capital Partners to Acquire Express Scripts’ Subsidiary United BioSource | PR Newswire | 11/27/2017

Avista Capital Partners to Acquire Express Scripts’ Subsidiary United BioSource News provided by 09:15 ET Share this article ST. LOUIS and NEW YORK , Nov. 27, Express Scripts (NASDAQ: ESRX ) and Avista Capital Partners, a leading … integrated pharmacy benefit management services, including network-pharmacy claims processing home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services

Avista Capital Partners to Acquire Express Scripts’ Subsidiary United BioSource | PR Newswire | 11/27/2017

ST. LOUIS and NEW YORK , Nov. 27, Express Scripts (NASDAQ: ESRX ) and Avista Capital Partners, a leading private equity firm, announced today that Avista has signed a definitive agreement to acquire United BioSource (UBC), a … integrated pharmacy benefit management services, including network-pharmacy claims processing home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services

American Medical Association

Braeburn Announces Completion of $110 Million Financing | PR Newswire | 1/10/2018

… a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management, and Rock Springs … Mental Health Services Administration. According to the chair of the American Medical Association’s Opioid Task Force, only 20 percent of those who need treatment are receiving it. “Consistent with FDA Commissioner Gottlieb’s recent statement encouraging …

ACO

Braeburn Announces Completion of $110 Million Financing | PR Newswire | 1/10/2018

… a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management, and Rock Springs … with international pharmaceutical companies. On November 1, 2017 , the FDA’s Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee jointly voted 17-3 recommending approval of CAM2038 for the treatment of adults …

Psychosocial Support

Braeburn Announces Completion of $110 Million Financing | PR Newswire | 1/10/2018

… a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management, and Rock Springs … part of a comprehensive treatment plan to include counseling and psychosocial support. The product is designed for flexible and individualized treatment from initiation and stabilization to longer-term maintenance therapy, providing sustained buprenorphine release in …

Mental Health

Braeburn Announces Completion of $110 Million Financing | PR Newswire | 1/10/2018

… a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management, and Rock Springs … 1.1 million received MAT, according to the Substance Abuse and Mental Health Services Administration. According to the chair of the American Medical Association’s Opioid Task Force, only 20 percent of those who need treatment are …

Mental Health Services

Braeburn Announces Completion of $110 Million Financing | PR Newswire | 1/10/2018

… a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management, and Rock Springs … 1.1 million received MAT, according to the Substance Abuse and Mental Health Services Administration. According to the chair of the American Medical Association’s Opioid Task Force, only 20 percent of those who need treatment are …

Express Scripts

Express Scripts 2018 earnings forecast above estimates | Reuters | 12/14/2017

Reuters TV United States December 14, 2017 / 12:58 PM / Updated 2 minutes ago Express Scripts forecast 2018 profit above estimates, shares rise Reuters Staff 2 Min Read (Reuters) - Pharmacy benefit manager Express Scripts Holding Co … also included the sale of its United Biosource unit to Avista Capital Partners, which was announced last month. Express Scripts also increased its full-year 2017 adjusted earnings per share outlook to $7 to $7.08

Buyout Talk Intensifies As Express Scripts And Humana Shed Assets | Forbes | 11/29/2017

Nov 29, 2017 @ 07:55 AM Buyout Talk Intensifies As Express Scripts And Humana Shed Assets I write about healthcare business and policy Opinions expressed by Forbes Contributors are their own. Tweet This Signage outside the … pharmaceutical support business , United BioSource Corporation, to private equity firm Avista Capital Partners for an undisclosed amount. Express Scripts and its standalone business model are under pressure as rivals form closer ties with health insurers

UnitedHealth

Physician practices increasingly turn to private equity for capital | Modern Healthcare | 4/26/2019

… they need funding to fuel that growth. Private equity is competing with hospital systems and large physician organizations, such as UnitedHealth Group’s OptumCare, for a share of ownership. “The fact is it’s becoming more complex … firm in 2011 and then sold to a different company, Avista Capital Partners in 2017. The practice expanded from about 30 to 40 physicians in two states before accepting private-equity money in 2011 to …

UnitedHealth Group

Physician practices increasingly turn to private equity for capital | Modern Healthcare | 4/26/2019

… they need funding to fuel that growth. Private equity is competing with hospital systems and large physician organizations, such as UnitedHealth Group’s OptumCare, for a share of ownership. “The fact is it’s becoming more complex … firm in 2011 and then sold to a different company, Avista Capital Partners in 2017. The practice expanded from about 30 to 40 physicians in two states before accepting private-equity money in 2011 to …

Ameritox

Avista Capital Partners Completes Acquisition of Miraca Life Sciences | CNBC | 11/21/2017

IRVING, Texas and NEW YORK, Avista Capital Partners (“Avista”), a leading private equity firm, today announced the completion of its acquisition of Miraca Life Sciences (“MLS” or the “Company”) from Miraca Holdings Inc. MLS is … MLS. Mr. Walton most recently served as President & CEO of Ameritox, a leader in pain medication monitoring. Mr. Walton has more than two decades of experience as a founder and executive of health care businesses

LabCorp

Avista Capital Partners Completes Acquisition of Miraca Life Sciences | CNBC | 11/21/2017

IRVING, Texas and NEW YORK, Avista Capital Partners (“Avista”), a leading private equity firm, today announced the completion of its acquisition of Miraca Life Sciences (“MLS” or the “Company”) from Miraca Holdings Inc. MLS is … the company’s Esoteric Business Unit and was a member of LabCorp’s five-person Executive Committee. He also previously served as LabCorp’s head of Strategic Planning and Corporate Development, as well as the company’s Chief Information

Centerview Partners

New York’s Answer to Davos: Wall Street Pong, Louis Armstrong - Bloomberg | 1/26/2018

Centerview Partners, Credit Suisse, Davidson Kempner and Scopia Capital Management also sent players, and WeWork hosted a pre-party. Andrew Lipman of TA McKay & Co. and Phil Seskin of Avista Capital Partners founded the event to raise money and recruit mentors. It’s played on the squash court set up for the JPMorgan Tournament of Champions, and is held on the day of that competition’s finals. Honoring Satchmo Louis Armstrong’s song …

Avista Capital Partners to Acquire Express Scripts’ Subsidiary United BioSource | PR Newswire | 11/27/2017

Avista Capital Partners to Acquire Express Scripts’ Subsidiary United BioSource News provided by 09:15 ET Share this article ST. LOUIS and NEW YORK , Nov. 27, Express Scripts (NASDAQ: ESRX ) and Avista Capital Partners, a leading … company’s services and help it realize its full growth potential.” Centerview Partners LLC acted as financial advisor and Bryan Cave LLP acted as legal counsel to Express Scripts. Ropes & Gray LLP acted as legal counsel

Frazier Healthcare Partners

Physician practices increasingly turn to private equity for capital | Modern Healthcare | 4/26/2019

… and burdensome to manage a physician practice,” Ryan Lucero, a vice president in the Seattle office of private-equity firm Frazier Healthcare Partners, said during an event in New York on Thursday hosted by the … firm in 2011 and then sold to a different company, Avista Capital Partners in 2017. The practice expanded from about 30 to 40 physicians in two states before accepting private-equity money in 2011 to …

Deerfield Management

Braeburn Announces Completion of $110 Million Financing | PR Newswire | 1/10/2018

PRINCETON, N.J. , Jan. 10, 2018 /PRNewswire/ – Braeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management, and Rock Springs Capital. Apple Tree Partners, the sole investor in Braeburn to date, also participated. Braeburn will use the proceeds …

New Leaf Venture Partners

Braeburn Announces Completion of $110 Million Financing | PR Newswire | 1/10/2018

PRINCETON, N.J. , Jan. 10, 2018 /PRNewswire/ – Braeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management, and Rock Springs Capital. Apple Tree Partners, the sole investor in Braeburn to date, also participated. Braeburn will use the proceeds …

Apple Tree Partners

Braeburn Announces Completion of $110 Million Financing | PR Newswire | 1/10/2018

PRINCETON, N.J. , Jan. 10, 2018 /PRNewswire/ – Braeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management, and Rock Springs Capital. Apple Tree Partners, the sole investor in Braeburn to date, also participated. Braeburn will use the proceeds …

RA Capital Management

Braeburn Announces Completion of $110 Million Financing | PR Newswire | 1/10/2018

PRINCETON, N.J. , Jan. 10, 2018 /PRNewswire/ – Braeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management, and Rock Springs Capital. Apple Tree Partners, the sole investor in Braeburn to date, also participated. Braeburn will use the proceeds …

Rock Springs Capital

Braeburn Announces Completion of $110 Million Financing | PR Newswire | 1/10/2018

PRINCETON, N.J. , Jan. 10, 2018 /PRNewswire/ – Braeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management, and Rock Springs Capital. Apple Tree Partners, the sole investor in Braeburn to date, also participated. Braeburn will use the proceeds …

Rothschild & Co

Karo Pharma buys Swedish consumer healthcare firm Trimb | PE Hub | 6/25/2019

… for about $366 million. The deal is expected to close before the end of the year. Trimb was backed by Avista Capital Partners. PRESS RELEASE NEW YORK and STOCKHOLM, June 25, 2019 /PRNewswire/ — Avista Capital … Finance and White & Case acted as advisors to Karo Pharma. Rothschild & Co and Ropes & Gray acted as advisors to Avista Capital Partners and other shareholders. About Avista Capital Partners Founded in 2005, Avista is a …

Karo Pharma To Acquire Trimb Healthcare from Avista Capital Partners | PR Newswire | 6/25/2019

NEW YORK and STOCKHOLM , June 25, Avista Capital Partners (“Avista”), a leading private equity firm focused on growth-oriented healthcare businesses, announced the signing of a definitive agreement whereby Karo Pharma AB (publ) (“Karo Pharma … our successful growth journey in partnership with Karo Pharma.” Advisors Rothschild & Co and Ropes & Gray acted as advisors to Avista Capital Partners and other shareholders. SEB Corporate Finance and White & Case acted as advisors to

HCA

Karo Pharma To Acquire Trimb Healthcare from Avista Capital Partners | PR Newswire | 6/25/2019

NEW YORK and STOCKHOLM , June 25, Avista Capital Partners (“Avista”), a leading private equity firm focused on growth-oriented healthcare businesses, announced the signing of a definitive agreement whereby Karo Pharma AB (publ) (“Karo Pharma”), a specialty pharma company, will acquire Trimb Healthcare (“Trimb”) for approximately SEK 3.4 billion. The transaction is subject to customary competition authority review and is expected to close later this year. Founded in 2012, Trimb …

Physician practices increasingly turn to private equity for capital | Modern Healthcare | 4/26/2019

… burdensome to manage a physician practice,” Ryan Lucero, a vice president in the Seattle office of private-equity firm Frazier Healthcare Partners, said during an event in New York on Thursday hosted by the law … firm in 2011 and then sold to a different company, Avista Capital Partners in 2017. The practice expanded from about 30 to 40 physicians in two states before accepting private-equity money in 2011 to …

CityMD

Physician practices increasingly turn to private equity for capital | Modern Healthcare | 4/26/2019

… going down.” New York providers have captured some of that money. North American Partners in Anesthesia, Schweiger Dermatology Group and CityMD are just a few of the organizations that have used private-equity money to … firm in 2011 and then sold to a different company, Avista Capital Partners in 2017. The practice expanded from about 30 to 40 physicians in two states before accepting private-equity money in 2011 to …

Scott Walton

Miraca Life Sciences Announces Company Name Change to Inform Diagnostics | Business Wire | 1/9/2018

Avista Capital Partners from previous owner Miraca Holdings. The name Inform Diagnostics and new logo were chosen to highlight the company’s focus on providing pathology and diagnostic capabilities that together help inform clinicians and their patients about critical, health-related issues. “Although our name has changed to Inform Diagnostics, our services and dedication to our clinician clients remain constant,” said Scott Walton , who was named CEO of Inform Diagnostics last …

Jonathan Finkelstein

Physician practices increasingly turn to private equity for capital | Modern Healthcare | 4/26/2019

Avista Capital Partners in 2017. The practice expanded from about 30 to 40 physicians in two states before accepting private-equity money in 2011 to about 100 doctors in seven states, said Dr. Jonathan Finkelstein, regional medical director at New York Spin & Pain in Babylon, N.Y. “It’s allowed us to expand and bring under the umbrella, not only more physicians, but more patients,” he said. “One of the benefits of …

Mike Derkacz

Braeburn Announces Completion of $110 Million Financing | PR Newswire | 1/10/2018

… a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management, and Rock Springs … approved, for which the FDA has granted priority review,” said Mike Derkacz , President and CEO of Braeburn. “With opioid overdose now the leading cause of death among Americans under the age of 50, at Braeburn …